Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy

Human Pathology

Volumn 39, Issue 10, 2008, Pages 1511-1518

  Jeong, Hyeon Joo ^a   Park, Su Kil ^b   Cho, Yong Mee ^b   Kim, Myoung Soo ^a   Kim, Yu Seun ^a   Choi, Jung ^b   Kim, Soon Il ^a   Lim, Beom Jin ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Graft survival; Histology; IgA nephropathy; Recurrence

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; PREVALENCE; PROTEINURIA; QUANTITATIVE ANALYSIS; RECURRENT DISEASE;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; BIOPSY; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MICROSCOPY, FLUORESCENCE; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 50649111175     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.03.003     Document Type: Article

References (24)

1. Andresdottir M.B., Haasnoot G.W., Doxiadis I.I.N., Persijn G.G., and Claas F.H.J. Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data. Transplantation 80 (2005) 1012-1018
2. Frohnert P.D., Donadio J.V., Velosa J.A., Holley K.E., and Sterioff S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 11 (1997) 127-133
3. Choy B.Y., Chan T.M., Lo S.K., Lo W.K., and Lai K.N. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 18 (2003) 2399-2404
4. Kessler M., Hiesse C., Hestin D., Mayeux D., Boubenider K., and Charperitier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 28 (1996) 99-104
5. Odum J., Peh C.A., Clarkson A.R., et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9 (1994) 309-312
6. Ohmacht C., Kliem V., Burg H., et al. Recurrent immunoglobulin A nephritis after renal transplantation; a significant contributor to graft loss. Transplantation 64 (1997) 1493-1496
7. McDonald S.P., and Russ G.R. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 82 (2006) 759-762
8. Ponticelli C., Traversi L., Feliciani A., Cesana B.M., Banfi G., and Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int 60 (2001) 1948-1954
9. Kim Y.S., Moon J.I., Jeong H.J., et al. Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Transplantation 71 (2001) 233-238
10. Jeong H.J., Kim Y.S., Kwon K.W., et al. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Pathol Int 54 (2004) 837-842
11. Kim Y.S., Jeong H.J., Kwon K.W., Lee H.Y., Han D.S., and Park K. Live donor renal transplantation in patients with end-stage renal failure due to IgA nephropathy: clinicopathological assessment. Nephrology 7 (2002) S74-S77
12. Kowalewska J., Yuan S., Sustento-Reodica N., et al. IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis 45 (2005) 167-175
13. Butani L., Berg G., and Makker S.P. Microhematuria after renal transplantation in children. Pediatr Nephrol 17 (2002) 1038-1041
14. Kim Y.S., Jeong H.J., Kim M.S., Kim S.I., Han D.S., and Park K. Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria?. Clin Transplant 12 (1998) 104-108
15. Ji S., Liu M., Chen J., et al. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation. Clin Transplant 18 (2004) 536-540
16. Suzuki K., Honda K., Tanabe K., Toma H., Nihei H., and Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63 (2003) 2286-2294
17. Moriyama T., Nitta K., Suzuki K., et al. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant 19 Suppl 14 (2005) 41-48
18. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713-723
19. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36 (2000) 227-237
20. Mihatsch M.J., Thiel G., and Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 20 Suppl 3 (1988) 759-771
21. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., and Chapman J.R. Evolution and pathophysiology of renal-transplant glomerulosclerosis. Transplantation 78 (2004) 461-468
22. First M.R., Vaidya P.N., Maryniak R.K., et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation 38 (1984) 607-612
23. Jeong H.J., Kim Y.S., Kwon K.W., et al. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril. Clin Transplant 17 (2003) 108-113
24. Oka K., Imai E., Moriyama T., et al. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 15 (2000) 689-695